Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), ranging from asymptomatic conditions to severe/fatal lung injury and multi-organ failure. Growing evidence shows that the nasopharyngeal microbiota composition may predict the severity of...

Full description

Bibliographic Details

Published in:	Frontiers in Cellular and Infection Microbiology
Main Authors:	Luca Ferrari, Chiara Favero, Giulia Solazzo, Jacopo Mariani, Anna Luganini, Monica Ferraroni, Emanuele Montomoli, Gregorio Paolo Milani, Valentina Bollati, UNICORN Consortium, Benedetta Albetti, Claudio Bandi, Tommaso Bellini, Matteo Bonzini, Marco Buscaglia, Carlo Cantarella, Laura Cantone, Michele Carugno, Sergio Casartelli, Sarah D’Alessandro, Francesca De Chiara, Serena Delbue, Ivano Eberini, Laura Galastri, Cristina Galli, Simona Iodice, Carlo La Vecchia, Chiara Macchi, Alessandro Manenti, Ilaria Manini, Serena Marchi, Elena Pariani, Federica Rota, Angela Cecilia Pesatori, Massimiliano Ruscica, Tommaso Schioppo, Letizia Tarantini, Claudia Maria Trombetta, Marco Vicenzi, Giuliano Zanchetta
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Subjects:	UNICORN SARS-CoV-2 nasopharyngeal bacterial microbiota immunoglobulins asymptomatic carriers
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.882302/full